Daniel Isaza

Daniel Isaza-Restrepo, MD, FACC - Cardiólogo e Intensivista, Director Unidad de Cuidado Coronario LaCardio @fcardioinfantil

[Dhruv Kazi @kardiologykazi]

Excited to see our first-ever #CKM syndrome guidelines out—a herculean effort to distill the evidence and advance care. Ensuring that high-quality care is available to all will require strategic investments in access and #affordability. @SmithBIDMC

[AHA Science @AHAScience]

Published today, the first-ever clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome from the American Heart Association and @ACCinTouch.

The focus of this clinical practice guideline is to create a living, working document that provides current knowledge in the field of CKM syndrome aimed at all practicing cardiologists, endocrinologists, nephrologists, and primary care and specialty clinicians who manage these patients.

✍🏼 @ChiadiNdumele @HeartDocSadiya @kardiologykazi @noshreza @virani_md @biykemb @NutritionHF @mandeepbajaj65 @KatherineTuttl8 @RangaswJ @lisaVWMD @KBreathettMD @EmoryFamMed @ShoaClarke @mad_sters @jmortonmd @sripalbangalore @AnumSaeedMD

[Heart_BMJ @Heart_BMJ]

Identification and management of non-obstructive high-risk coronary artery plaque

Please read the article and enjoy an in-depth interview between @jhfrudd and the first author, University of Edinburgh's Dr Craig Balmforth

Publication - https://t.co/j3ZQk2CNPa

Podcast - https://t.co/qPPLSvTdhj

[C. Michael Gibson MD @CMichaelGibson]

I sat down with my mentor Dr. Eugene Braunwald for a 3 part series about his life.

In part 1 we talk about his early years:
"Everything changed on March 12, 1938 when Hitler marched in with the Nazis & my father was arrested"

Hear how they escaped here

For better video quality view here: https://t.co/1l3DhounN4

[TIMI Study Group @TIMIStudyGroup]

We are deeply saddened to have lost our founding chairman and the father of modern academic cardiology, Dr. Eugene Braunwald, who founded the TIMI Study Group in 1984, and with that vision profoundly shaped the practice of cardiovascular medicine across the world.

[Eric Topol @EricTopol]

Here are the 2 accompanying editorials, diametrically opposed!

[C. Michael Gibson MD @CMichaelGibson]

STEMI-DTU trial: Combination of the Impella CP plus device a 30-minute delay to PCI did not reduce infarct size vs. immediate PCI in patients with anterior STEMI without shock. #ACC26 View slides here: https://t.co/yzmg7CwT0k

[NEJM @NEJM]

Presented at #ACC26:

In patients with atrial fibrillation, left atrial appendage closure was noninferior to NOACs in an analysis of death from cardiovascular causes, stroke, or systemic embolism and was superior for non–procedure-related bleeding. Full CHAMPION-AF trial results: https://t.co/5Uv4N1HXXn

Editorial: Left Atrial Appendage Closure — Should Recommendations Be Expanded? https://t.co/afTN59ySIA

@ACCinTouch

[Daniel Isaza @danielisazamd]

The Big Shift in Cardiology to Atheroma and Inflammation https://t.co/TDBuTldBBA

[Eric Topol @EricTopol]

The era of the GLP-1 family of drugs is still in the early days. These gut peptides talk to the brain and immune system and there are so many more in development, in combination, in pills, to come.

[Rishi Wadhera, MD MPP @rkwadhera]

Wonderful to host @DrCaliff_FDA - our visiting "chief provocateur" - for @SmithBIDMC Grand Rounds @BidmcCvi

A rich and thought-provoking discussion on health care, social inequality, public health, and the role of communication & trust.

[Daniel Isaza @danielisazamd]

Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology | JACC https://t.co/NOUlQco1oR

[Bashaer Gheyath MD FACC 🫀👩🏻‍⚕️ @Bgheyath]

@ChrisKramerMD high yield talk (a thread 1/4) AN(O)CA, INOCA & MINOCA – umbrella terms for patients with non-obstructive CAD (<50% stenosis).
•MINOCA: MI + troponin elevation + angina
•INOCA: Ischemia + angina, no troponin
•ANOCA: Angina only
#ACCMidEast @ACCinTouch

[Dhruv Kazi @kardiologykazi]

🚨 A new, practical framework for evaluating the economic value of cardiovascular drugs, devices, and preventive strategies
Just published in @JACCJournals and @CircAHA

Here’s what’s new, why it matters, and how it will shape care. 🧵

[Pablo Corral MD @drpablocorral]

🙌 Muchas gracias a toda la comunidad de @fcardioinfantil por la invitación.
Un placer poder participar junto a @Drlipid

[Daniel Isaza @danielisazamd]

Dr Pablo Corral @drpablocorral 🇦🇷en conferencia acerca de Lipoproteina (a) en @fcardioinfantil 🇨🇴

[Daniel Isaza @danielisazamd]

2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | JACC https://t.co/JN1Bs4Paf7

[European Society of Cardiology @escardio]

#ESCCongressVisuals from Hot Line 8👇

Will the ALONE-AF trial demonstrate that patients with AF who have at least one non-gender stroke risk factor & no documented recurrence of AF after 12 months receiving apixaban have a lower composite of stroke, systemic embolism and bleeding? 👇

PFA has gained traction given its simplicity recently. Will the BEAT PAROX AF trial prove that this technology provides superior results compared with the previously employed ablation techniques? 👇

Are we charting the future of more precise ablation using digital twin-guided rotor ablation? The CUVIA-PRR brings the future to us today. 👇

#ESCCongress

[Daniel Isaza @danielisazamd]

2025 ESC Guidelines for the management of myocarditis and pericarditis | European Heart Journal | Oxford Academic https://t.co/jtwM3rWvXY

[Int’l Society for Adult Congenital Heart Disease🌎 @ISACHD]

@ISACHD #Case of the #Month
Congratulations to 🇨🇴 team @fcardioinfantil

1/ 🫀
A 27-year-old woman with a history of dextro-transposition of the great arteries (D-TGA) repaired by Mustard procedure as an infant develops worsening shortness of breath.
What happened next shows the power of multimodal imaging & multidisciplinary teamwork.
#CardioTwitter #ACHD